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http://www.cardiothoracicsurgery.org/content/7/1/69RESEARCH ARTICLE Open AccessElective minimally invasive coronary artery
bypass: Shunt or tournique occlusion?
Assessment of a protective role of perioperative
left anterior descending shunting on myocardial
damage. A prospective randomized study
Zdenek Sorm1, Jan Vojacek1, Eva Cermakova2, Radek Pudil3, Ulrich A Stock4 and Jan Harrer1*Abstract
Background: To determine impact of intraluminal-left anterior descending shunt to prevent myocardial damage in
minimally invasive coronary artery bypass.
Methods: 38 patients were randomly assigned to external tournique occlusion (n = 19) or intraluminal-left anterior
descending shunt group (n = 19). Blood samples for cardiac troponin T were collected at 30 minutes prior to, 6 and
24 hours after surgery.
Results: One patient in external tournique occlusion and two patients in intraluminal-left anterior descending shunt
group were excluded from futher analysis due to preoperative cardiac troponin T level above the 99th-percentile.
Postoperatively, each six patients in external tournique occlusion (33.3%) and intraluminal-left anterior descending
shunt (35.3%) group were above the 99th-percentile. Two patients from each group (external tournique occlusion
group 11.1% vs. intraluminal-left anterior descending shunt group 11.8%) had peak values above 10-% coeficient of
variation cutoff (p= 1). There were no significant differences in between both groups at all studied timepoints.
Conclusion: There was no protective effect of intraluminal shunting on myocardial damage compared to
short-term tournique occlusion. It is upon the surgeon's discretion which method may preferrably be used
to achieve a bloodless field in grafting of the non-occluded left anterior descending in minimally invasive
coronary artery bypass.
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Minimally invasive direct coronary artery bypass grafting
(MIDCAB) is an excellent option for treatment of the
patients with isolated stenotic or occluded left anterior
descending coronary arteries (LAD) and selected
patients with multivessel disease [1]. MIDCAB limits the
patient burden and provides excellent long-term patency
[2]. Bloodless operating field remains one of the most* Correspondence: jharrer@seznam.cz
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reproduction in any medium, provided the orimportant prerequisite to perform perfect coronary
anastomosis on the beating heart, especially in the case
of the limited skin incision via left anterior mini-
thoracotomy. Tournique occlusion or shunting of the
target artery are two established methods to achieve this
condition. External tournique occlusion (TO) of the
LAD may cause transient perioperative anterior wall
dysfunction [3,4], postoperative myocardial stunning
[5,6] or increasing serum concentrations of cardiac
troponin (cTn) [7]. Increased postoperative cardiac mar-
kers correlate with an impaired outcome after coronary
artery bypass grafting (CABG) [8]. Intraluminal-LAD
shunt (ILS) has proven to preserve segmental walltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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myocardial perfusion [9], reduces myocardial damage
[7], shows a trend towards improved intra- and post-
operative angiografic results [4], improve visualization
and allow surgeons to perform the anastomosis in an
unhurried and technically precise manner [10].
Clinical and histopathological safety of tournique oc-
clusion or intraluminal shunt technique remains contro-
versial [11-15]. The aim of this study was to evaluate the
benefit of intraluminal-LAD shunt on myocardial dam-
age in MIDCAB patients.
Methods
Patients
From April 2005 to August 2009 145 MIDCABs were
performed at Department of Cardiac Surgery, Charles
University in Prague, Faculty of Medicine and University
Hospital Hradec Kralove, Czech Republic.
Of those, 38 patients met inclusion criteria and were
randomly assigned to a external tournique occlusion
group (TO group; n = 19) or a intraluminal-LAD shunt
group (ILS group; n = 19). All patients included in the
study were operated by the same supervised trainee and
by the same consultant. The study was approved by the
local ethics committe, informed consent was obtained
from all patients. The exclusion criteria for the study
were history of occlusion or myocardial infarction in
the LAD territory, concomittant occlusion of both cir-
cumflex artery and right coronary artery, impaired left
ventricular ejection fraction (LV EF) of less than 25%
assessed by echocardiogram, redo-surgery, emergency
operations, recent myocardial infarction (MI): <
3 weeks, renal insuficiency with serum creatinine level
of more than 200 ug/L, age of< 18 years and of >
80 years.
The reasons for incomplete revascularization in 10
patients with double vessel disease were very small
diameter of target vessels< 1.0-mm (7 patients) and
intended percutaneous coronary intervention (PCI) on
the other coronary artery after recovery from the oper-
ation (3 patients). Decision to perform hybrid MIDCAB
procedure was made preoperatively by the heart team
(cardiac surgeon and cardiologist).
Anesthetic and surgical technique
Anesthetic technique consisted of propofol infusion at
1 mg/kg/h combined with sufentanyl infusion at
0,5 μg/kg/h. Neuromuscular blockade was achieved by
0.04 mg/kg/h cisatracurium. Patients were normocapnic
ventilated using isoflurane (Forane, Abbot Laboratories,
GB; 0,7–0,8%). Betablockers were applicated throughout
the cardiac procedure. A left anterior minithoracotomy
was made in the 4th or 5th intercostal space (length of
the incision was at an average 8 centimeters). Leftinternal thoracic artery (LITA) was harvested under dir-
ect vision as a pedicled conduit. The patients were
heparinized (100 IU/kg); the activated clotting time
(HEMOCHRONW International Technidyne Corpor-
ation, Edison, USA) was kept at 300 seconds throughout
the operation and was neutralized incompletely with a
half dose of Protamine after completion of the anasto-
mosis. Once the target region for the anastomosis on
the LAD was identified, silicon loops in a figure-of-eight
(Quest Medical, Inc, Allen, TX) were placed proximally
in all patients. Very gentile stabilization of the heart with
a mechanical stabilizer (CardioThoracic System, Inc,
Cupertino, CA or StableSoftTM Ultra Stabilizer, Estech)
was done. The proximal silicon loop was slightly ele-
vated to avoid excessive bleeding during introduction of
the intraluminal shunt after arteriotomy in the ILS
group. The size (1.25, 1.5, 1.75 mm) of the shunt (Gui-
dant Axius, Boston Scientific, Santa Clara, CA) were
determined according to the target vessel diameter by
the surgeon, oversizing was avoided. The shunt was
removed prior to completion of the anastomosis. In
the TO group ischemic preconditioning consisting of
3 minutes (min.) of ischemia and 5 min. of reperfu-
sion was performed. The proximal tournique occlusion
was maintained throughout completion of the anasto-
mosis with running 7–0 polyprolylene suture (Prolen,
Visi-black, Ethicon) in both groups. Excellent visibility
was accomplished with a surgical blower (AxiusTM
Blower/Mister, Maquet Cardiovascular LLC, Wayne,
NJ). The open left pleural cavity was drained in all
patients and the chest wall sutured in layers. To pre-
vent chest pain after the operation, an intercostal
nerve blockade was applied using 20 cc 0.5% bupiva-
caine hydrochloride (Solupharm GmbH, Melsungen,
Germany) infiltration.
ECG
All patients had a twelve lead electrocardiogram (ECG)
assessment prior surgery, daily on intensive care unit
(ICU) and at discharge. ECGs were independently ana-
lyzed by two observers who were blinded to the subse-
quent groups and outcome.
For intraoperative ECG on-line monitoring (Draeger
Medical Inc., Telford, USA) with electrodes placed in
the standard fashion was performed. ST-segment
changes in lead V5 were included in the analysis.
Cardiac troponin T
Three samples of central venous blood in each patient
were analysed: 30 min. prior to surgery (baseline), 6 and
24 hours after the operation. The highest cTnT value
during first 24 hours after operation was considered as
peak cTnT serum concentration in each patient and was
included in the analysis. cTnT was measured with an






Age*, years 62.9 ± 11.2 68.2 ± 9.2 0.14
Body mass index* 28.3 ± 3.9 29.8 ± 3.1 0.20
Female, n 4 (22.2) 2 (11.8) 0.66
Cerebrovascular disease, n 1 (5.6) 4 (23.5) 0.18
Diabetes mellitus, n 2 (11.1) 3 (17.6) 0.79
Previous myocardial
infarction, n
6 (33.3) 4 (23.5) 0.71
Percutaneous coronary
intervention, n
8 (44.4) 6 (35.3) 0.73
Peripheral vascular disease, n 1 (5.6) 0 (0) 1.00
History of unstable angina
pectoris, n
5 (27.8) 2 (11.8) 0.40
Smoking, n 9 (50) 10 (58.8) 0.74
Atrial fibrillation, n 3 (16.7) 2 (11.8) 1.00
Left main stenosis, n 0 (0) 0 (0) 1.00
1-vessel disease, n 13 (72.2) 12 (70.6) 1.00
2-vessel disease, n 5 (27.8) 5 (29.4) 1.00
LAD stenosis
50–70%, n 3 (16.7) 3 (17.6) 1.00
> 70%, n 15 (83.3) 14 (82.4) 1.00
Beta-blocker administration, n 16 (88.9) 12 (70.6) 0.23
Acetyl salicylic acid
administration, n
1 (5.6) 2 (11.8) 0.60
Ejection fraction†, % 62; 60–65 65; 60–70 0.34
EuroSCORE† 2.08; 1.31–2.69 2.21; 1.33–2.69 0.99
Hypertension, n 14 (77.8) 14 (82.4) 1.00
Hyperlipidemia, n 13 (72.2) 10 (58.8) 0.49
Chronic obstructive
pulmonary disease, n
0 (0) 0 (0) 1.00
Serum creatinin level*, mmol/L 80.6 ± 17.4 92.2 ± 16.5 0.051
* Values are expressed as mean ± SD.
† Values are expressed as median; 95%LCL-95%UCL.
Values in parentheses are percentages.
TO= tournique occlusion; LAD= left anterior descending; ILS = intraluminal-LAD
shunt.
EuroSCORE= the European system for cardiac operative risk evaluation;
SD= standard deviation; LCL = lower confidence limit; UCL = upper confidence
limit.
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GmbH, Mannheim, Germany) with current commer-
cially available cTnT immunoassay (fourth generation).
This has lower limit of detection (LLD) of 0.01 μg/L, a
coeficient of variation (CV) ≤10% at 0.03 μg/L, and a
99th percentile cutoff at 0.01 μg/L.
Criteria for myocardial necrosis and for CABG-related
myocardial infarction (MI)
The cutoff for myocardial necrosis was determined to be
0.03 μg/L using the 10% total imprecision CV criteria
(10-% CV cutoff ).
Increases of cTnT serum concentration greater than
quintuple of 10-% CV cutoff was determined as CABG-
related MI [8].
Statistical considerations
Statistical analysis was performed using the NCSSW 7
software at the 5% statistical significance level. The cat-
egorical data was analyzed by the Fisher's exact test (in-
cluding cTnT analysis). The Mann–Whitney U-test,
Kolmogorov-Smirnov and the Student unpaired t-test
were used for the quantitative data. The variables in
tables are expressed as the average ± standard deviation
(SD) or as the median; 95% lower confidence limit (LCL)
– 95% upper confidence limit (UCL).
Results
One patient from TO group and two patients from ILS
group were excluded from further analysis due to
increased preoperative cTnT levels (above the 99th-
percentile [0.01 μg/L]).
Patients characteristics
Clinical and angiographic characteristics are depicted in
Table 1. There were no significant differences between
groups undergoing MIDCAB.
Intra-operative results
There were no conversion to sternotomy in our
patients. The anastomotic time in TO group was sig-
nificantly shorter than in ILS group (13.44 ± 5.06 vs
18.9 ± 6.56 min., p= 0.0094).
Intraoperative reversible ST segment deviations in pre-
cordial lead V5 were comparable in both groups (TO
group: median 0.1 mV, range 0–1.4 mV vs ILS group:
median 0.1 mV, range: 0 – 1.1 mV, p= 0.69). Intraopera-
tive date are summarized in Table 2.
cTnT analysis
All patients included in the analysis had values of pre-
operative cTnT serum concentrations below LLD
(<0.01 μg/L). Postoperatively, six patients from TO
group (33.3%) and six patients from group ILS group(35.3%) were above the 99th-percentile (0.01 μg/L). Two
patients from each group (TO group 11.1% and ILS
group 11.8%) had peak values above the 10-% CV cutoff
(0.03 μg/L) but did not exceed its quintiple diagnostic
for coronary artery bypass grafting (CABG)-related MI.
These four patients were indicative of peri-procedural
myocardial necrosis. Distribution of the patients with
cTnT values above the 99th-percentile and above the
10-% CV cutoff were similar, the groups did not differ
(p= 1) from each other (Figure 1).









13.4 ± 5.1 18.9 ± 6.6 0.0094
Heart rate†,
beats/min.
58.5; 57–62 60; 57–60 0.84
Systolic blood pressure*,
mmHg
106.2 ± 7.4 109.5 ± 7.5 0.19
Diastolic blood pressure*,
mmHg
56.6 ± 3.7 59.2 ± 5.6 0.11
Central venous pressure*,
mmHg
5.8 ± 2.5 4.8 ± 2.4 0.23
ECG V5 ST segment shift†,
mV
0.1; 0.1–0.2 0.1; 0.1–0.2 0.69
Conversion, n 0 (0) 0 (0) 1.00
shunt introduction, n 0 (0) 17 (100)
* Values are expressed as mean ± SD.
† Values are expressed as median; 95%LCL-95%UCL.
Values in parentheses are percentages.
TO= tournique occlusion; ILS = intraluminal-left anterior descending shunt;
ECG= electrocardiogram; SD= standard deviation; LCL = lower confidence limit;
UCL = upper confidence limit.
Table 3 Postoperative complications
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There were only two patients with perioperative ECG
V5 ST segment shift above 1 mm in TO group (ST seg-
ment elevations 1.3 mV and 1.4 mV, anastomotis time
13 min. and 7 min.) with postoperative cTnT below LLD
(<0.01 μg/L). Perioperative ECG ST-segment alterations
of more than 1 mm was observed in only one patient
from ILS group (ST segment elevation of 1.1 mV). There
was prolonged shunt introduction (at about 3 min.) in
this patient because of unfavourable anatomy of the
LAD. Although the ST-segment elevation gradually van-
ished after shunt introduction, this patient had highest
postoperative peak cTnT among all patients (0.12 μg/L)
without further clinical consequences. Reversible peri-
operative ECG ST segment shifts were similar (p= 0.69)






















Figure 1 Distribution of peak cardiac troponin T serum
concentration postoperatively. cTnT= cardiac troponin T;
TO= tournique occlusion; ILS = intraluminal-left anterior
descending shunt.Post-operative results
Early mortality was zero. There were no twelve lead
ECGs changes after surgery in our patients. There were
no procedure-related myocardial infarctions and no
neurologic, renal, pulmonary, wound or other serious
complications observed. Rethoracotomy for bleeding was
required in one patient from TO group. Discrete signs
of low cardiac output (LCO) with catecholamines de-
pendency of> 24 hours (< 0.05 μg/kg/min) occured in
two patients from ILS group and in 4 patients from TO
group (p= 0.66). Five of these patients had postoperative
cTnT level below 10-% CV cutoff, one patient from TO
group had peak cTnT level 0.078 μg/L. Additional post-
operative echocardiography did not reveal new patologi-
cal findings in these LCO patients. Post-operative data
are summarized in Table 3.Discussion
Troponin remains the biomarker of choice for detection
of cardiac injury. Troponin assays are more sensitive and
more specific than CK-MB assays [16]. For all intents
and purposes, cTnI and cTnT provide comparable infor-
mation, except in patients with renal failure. Monitoring
cardiac biomarkers are prerequisites to improve
strategies for myocardial protection and surgical
approaches [17].
Gürbüz at al. demonstrated in a small patient cohort
that patients with isolated LAD lesions undergoing off-
pump coronary artery bypass grafting (OPCAB) with
intraluminal shunt revealed statistically less troponin I
(cTnI) compared to no-shunt patients (p= 0.003). The
observed discrete cTnT “leaks“in both groups may ori-
ginate from “cytosolic pool“(unbound troponin) or from
contractile apparatus in myofibrils (structurally bound
troponin) [18]. The authors recommend the consequent





Blood losses†, ml 325; 300–450 350; 300–450 0.91
Rethoracotomy for bleeding, n 1 (5.6) 0 (0) 1.00
New atrial fibrillation, n 4 (22.2) 4 (23.5) 1.00
Low cardiac output
IABP necessary, n 0 (0) 0 (0) 1.00
Prolonged catecholamines
> 24 hours, n
4 (22.2) 2 (11.8) 0.66
Pleural effusion, n 1 (5.6) 0 (0) 1.00
† Values are expressed as median; 95%LCL-95%UCL.
Values in parentheses are percentages.
TO= tournique occlusion; ILS = intraluminal-left anterior descending shunt;
IABP = intraaortic balloon pump; LCL = lower confidence limit; UCL = upper
confidence limit.
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multivessel disease (MVD) and moderate left ventricular
dysfunction [19].
To our knowledge there are no published results in
the literature regarding any OPCAB or MIDCAB studies
comparing intraluminal shunting and tournique occlu-
sion by means of cTnT during isolated revascularisation
of the LAD. Accordingly any comparison of our results
with above mentioned studies remains difficult. In con-
trast to the currently used cTnT assay, the approximately
10–20 cTnI immunoassays that have been developed use
different antibodies directed against different epitopes
and different calibrators and control materials [20,21].
However, contrary of the Gürbüz study, we could not
confirm protective effect of the intraluminal shunting on
myocardial damage in our MIDCAB patients. Gumm
et al. examined the effect of risk area size on collateral
resistance and ischemic region perfusion during LAD
occlusion at different sites. They concluded, that small
risk areas have significantly lower collateral resistance
and receive more collateral flow per mass of tissue com-
pared to large risk areas [22]. A potential explanation to
the differing results of Gürbüz compared to our study
might be the fact that the anastomotic site of the LAD
in MIDCAB is placed more peripherally than in
OPCAB.
At this time the discussion whether intraluminal-LAD
shunting can provide a minimal blood flow for adequate
myocardial protection, especially shunts of lower diam-
eter remains controversal [23].
There are several concerns regarding intraluminal
shunts versus tournique occlusion technique in off-
pump revascularization. Zimarino et al. used intraopera-
tive transoesophageal echocardiography (TEE) to assess
the effects of prolonged LAD (TIMI flow 0–3) occlusion
on myocardial dysfunction during MIDCAB, and evalu-
ated the impact of myocardial ischemia on long-term
outcome [5]. If the duration of ischemia of the LAD ter-
ritory is limited to 30 minutes no apparent persistent
wall motion abnormalities were observed. He concluded,
that MVD, but not perioperative ischemia or stunning,
predicts long-term event-free survival. Menon et al.
tested the effectiveness of temporary intraluminal shunt-
ing during MIDCAB by using Swan-Ganz catheter and
TEE. They concluded that shunts prevent systolic dys-
function and suggests an improvement of early graft pa-
tency and low reintervention rate within the first 6
postoperative months [3]. Based on intra- and post-
operative angiography together with intraoperative TEE,
Bergsland et al. stated that intracoronary shunts prevent
ischemia (p= 0.004) during grafting of the LAD in
OPCAB and provides satisfactory immediate- and short-
term graft patency [4]. Nearly 30% of all patients devel-
oped de-novo LAD lesions (mostly proximal) near theanastomosis suggesting, that tournique occlusion even
temporarily to permit shunt insertion, is traumatic to
the coronary artery. The study should encourage more
OPCAB surgeons to shunt routinely and avoid any prox-
imal and distal tourniques.
Wippermann et al. have shown in an animal study that
intraluminal shunts cause only moderate trauma to the
vessel and may therefore be superior regarding acute
and chronic intimal integrity in contrast to tournique
occlusion [11,12]. In contrast, some investigators
revealed that intracoronary shunts might create a greater
degree of endothelial dysfunction compared to extravas-
cular devices such as bulldog clamps or double-looped
Gore-Tex suture snaring. They recommended to avoid
intraluminal shunts [13-15,24]. Both external occlusion
devices and intraluminal shunts may lead to target cor-
onary artery occlusions, septal myocardial infarction,
and distal embolization with atheromatous debris into
the coronary circulation in some cases [25,26].
However, occlusion time of more than 30 minutes is
known to potentially induce wall motion abnormalities
and arrhythmias [6]. Accordingly in cases of repeated or
difficult anastomosis an intracoronary shunt might be
helpful and recommended.
Limitations of the study
The inability to reliably quantify cTn in very low con-
centrations complicates a thorough data analysis. The
inadequacy of the current commercially available cTnT
assay (fourth generation) to distinguish potentially
discrete differences in myocardial damage between tech-
niques in MIDCAB is attributed both to the LLD being
higher than reference values and to assay imprecision
(i.e., CV) being >10% at the 99th-percentile value of the
reference population. The application of recently devel-
oped highly sensitive cTn immunoassays may help to
resolve this problem [20]. In general a study population
with a larger size are required to obtain more accurate
results.
Conclusion
Safety of tournique occlusion or intraluminal shunting
technique remains still controversial. Since 1997 we have
used proximal and distal snares during MIDCAB at our
department. After clinical introduction of shunts we
have changed our strategy and used shunts routinely. As
they can be occasionally difficult to insert or might dis-
place during completion of the anastomosis we critically
discussed tournique of the native vessel as an alternative
to ensure good visualization of the anastomotic site. The
results of our study confirmed this hypothesis by reveal-
ing no protective effect of intraluminal shunting on
myocardial damage compared to tournique occlusion.
Accordingly we changed our strategy again keeping it up
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achieve a bloodless field in grafting of the non-occluded
LAD in MIDCAB.
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